
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.210 | 1.940 | 0.730 |
Stocks | 98.650 | 98.650 | 0.000 |
Bonds | 0.130 | 0.130 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.610 | 17.819 |
Price to Book | 3.380 | 3.653 |
Price to Sales | 7.371 | 5.347 |
Price to Cash Flow | 15.838 | 13.558 |
Dividend Yield | 0.159 | 0.514 |
5 Years Earnings Growth | 9.463 | 19.484 |
Number of long holdings: 70
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 5.78 | 644.48 | -0.46% | |
Insmed | US4576693075 | 4.73 | 81.06 | -3.05% | |
Gilead | US3755581036 | 4.64 | 109.95 | -0.07% | |
Sarepta | US8036071004 | 3.68 | 106.28 | -1.96% | |
Blueprint Medicines Corp | US09627Y1091 | 3.30 | 92.25 | -2.23% | |
Vaxcyte | US92243G1085 | 3.24 | 79.74 | -3.31% | |
Alnylam | US02043Q1076 | 3.16 | 250.59 | -0.16% | |
Regeneron Pharma | US75886F1075 | 3.01 | 700.33 | +0.62% | |
TG | US88322Q1085 | 2.95 | 30.88 | -0.19% | |
Cytokinetics Inc | US23282W6057 | 2.68 | 50.26 | -1.68% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet Clean Energy I dy GBP | 3.48B | 2.80 | 9.66 | 10.56 | ||
Pictet Clean Energy P dy GBP | 3.48B | 2.72 | 8.68 | 9.61 | ||
Pictet USA Index R dy GBP | 2.67B | 3.58 | 13.64 | 14.56 | ||
Pictet Biotech P dy GBP | 1.39B | 7.79 | 10.47 | 4.64 | ||
Pictet Japanese Eq opp HI GBP | 166.85B | 2.25 | 18.20 | 10.51 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review